MAP1LC3A anticorps (AA 1-100)
Aperçu rapide pour MAP1LC3A anticorps (AA 1-100) (ABIN6143466)
Antigène
Voir toutes MAP1LC3A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-100
-
Séquence
- MPSDRPFKQR RSFADRCKEV QQIRDQHPSK IPVIIERYKG EKQLPVLDKT KFLVPDHVNM SELVKIIRRR LQLNPTQAFF LLVNQHSMVS VSTPIADIYE
-
Réactivité croisée
- Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Immunogène
- A synthetic peptide corresponding to a sequence within amino acids 1-100 of human MAP1LC3A (NP_115903.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000,IHC,1:50 - 1:200
-
Commentaires
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
-
Autre désignation
- MAP1LC3A
-
Sujet
- MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. The expression of variant 1 is suppressed in many tumor cell lines, suggesting that may be involved in carcinogenesis.,MAP1LC3A,ATG8E,LC3,LC3A,MAP1ALC3,MAP1BLC3,Cancer,Signal Transduction,Cell Biology & Developmental Biology,Autophagy,Cytoskeleton,Microtubules,Endocrine & Metabolism,Mitochondrial metabolism,Cardiovascular,Heart,ATGs,MAP1LC3A
-
Poids moléculaire
- 14 kDa
-
ID gène
- 84557
-
UniProt
- Q9H492
-
Pathways
- Autophagy
Antigène
-